Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in São Paulo State, Brazil

Vaccination of adults aged 60 years and older against Streptococcus pneumonia is not recommended in Brazil. The 23-valent polysaccharide pneumococcal vaccine (PPV23) is only available for institutionalized persons or with underlying diseases despite the substantial medical and economic burden relate...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Neto, Joao Tonolio, Branco de Araujo, Gabriela Tannus, Gagliardi, Anna, Pinho, Amanda, Durand, Laure, Fonseca, Marcelo
Médium: Artigo
Jazyk:Inglês
Vydáno: Landes Bioscience 2011
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256326/
https://ncbi.nlm.nih.gov/pubmed/21941088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.7.10.15987
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky